Purpose: To evaluate the necessity for additional surgical treatment after Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD), we analyzed the pathologic results of patients who underwent surgical treatment. Methods: 140 consecutive patients underwent additional surgical treatment after EMR/ESD with en bloc resection between April 2005 and November 2009 at ASAN Medical Center. Additional surgical treatments were undergone for following conditions such as incomplete dissection (involvement of margin), undifferentiated-type histology (≥2 cm) and submucosal cancer. Results: One patient with deep margin involvement displayed advanced gastric cancer after gastrectomy. Three of 74 patients with clear resection margin were confirmed to have residual cancer at ESD site and 2 of 3 patients displayed advanced gastric cancer after surgery. In univariate analysis for metastasis of lymph node, deep submucosal invasion (over sm2 or 500μm) and the presence of lymphovascular invasion showed significant differences for lymph node metastasis. Especially, lymphovascular invasion was an important predictive factor for lymph node metastasis in multivariate analysis. In analysis for residual cancer, lateral margin involvement and large tumor (＞3 cm) were risk factors. And, only lateral margin involvement showed significant risk in multivariate analysis. Conclusion: Although EMR/ESD were fully accomplished for resection margin, gastrectomy and lymph node dissection were positively necessary for patients with deepsubmucosal invasion (over sm2 or 500μm) and the presence of lymphovascular invasion to eliminate the possibility of residual cancer or more advanced gastric cancer or metastatic lymph nodes. (J Korean Surg Soc 2011;80:165-171)
INTRODUCTION
Early gastric cancer (EGC) is defined as being confined to the mucosa or the submucosa, regardless of regional lymph-node metastasis. and ESD were performed on the following conditions. 1) differentiated (well-and/or moderately differentiated adenocarcinoma and/or papillary carcinoma) type, mucosal cancer without ulcer, and any size, 2) differentiated type, mucosal cancer with ulcer, and 3 cm or smaller, 3) undifferentiated type, mucosal cancer without ulcer, and 2 cm or smaller, 4) no lymphovascular invasion and 5) depth of tumor' invasion, confined to the submucosal 1 (SM1; ∼500μm). (1, 14, 15) Recently, in our institution, we extended indications of ESD for patients with mucosal cancer without ulcer findings irrespective of tumor size, mucosal cancer with ulcer findings (≤3 cm) and minute (＜500 m from muscularis mucosae) submucosal invasive cancer (≤2 cm).
All patients with poorly differentiated type adenocarcinoma were excluded from ESD.
In our institution, before the ESD, EUS (Endoscopic Ultra-Sonography) and CT (Computed Tomography) gastrography were performed to evaluate the stage of patients.
In the present study, we therefore introduced the necessity of surgical treatment after EMR/ESD of EGC.
METHODS

1) Patient population and specimens
Between April 2005 and December 2009, 140 consecutive patients had received additional gastrectomy with lymph node dissection after the procedures of EMR/ESD in hospital. All EMR/ESD were performed by specialized enterologists. A single-channel endoscope (GIF-Q260, Olympus, Tokyo, Japan) was uses in patients under conscious sedation. Lesions were marked beyond a 5 mm margin using a conventional needle knife. A solution of epinephrine and methylene blue in normal saline was injected into the submucosal layer. Submucosal dissection with circumferential incision was performed using an insulated-tip diathermic (IT) knife. To confirm resection margin, the specimens containing tumors were sliced at intervals of 2 mm. In EMR procedures, the only difference was that dissection was performed by direct snaring using an oval device.
In this study, the criteria for surgical treatment were 1) mucosal cancer, with undifferentiated-type histology (＞2 cm) or involvement of margin and 2) submucosal cancer.
In all patients, the extent of lymph node dissection was over D1＋β. The surgically removed lymph nodes were histologically examined for metastasis.
2) Statistical analysis
Statistical analysis was performed using the "Statistical 
RESULTS
1) Demographics of patients
The clinical characteristics of 140 patients are presented in Table 1 . The ESD was performed in 130 of the 140 patients. In mucosal lesion, 50 patients had additional surgery for undifferentiated-type histology (＞2 cm) and lateral margin involvement. 105 of the 140 patients showed lesions at the lower part of the stomach. Laparoscopic gastrectomy was performed in 93 patients.
2) Incidence of residual cancer after EMR/ESD
In the pathological results, 29 of the 66 patients with incomplete resection margin showed residual cancer after gastrectomy. Thirty-six patients with only lateral margin involvement showed high residual cancer compared with vertical margin. Also, patients who were diagnosed with incomplete vertical resection margin showed advanced gastric cancer in the final pathologic results. Especially, 3
of the 74 patients with clear resection margin showed (Table 3 ). In univariate analysis for residual cancer, lateral margin, lateral and deep margin, and large tumor were significant predictive factors. Only lateral margin showed statistical significance in multivariate analysis (Table 4 ).
3) Incidence of lymph node metastasis
In univariate analysis, submucosal invasion with advanced depth (over sm2 or 500μm) and the presence of lymphovascular invasion had the statistical significance for metastatic lymph nodes. But in multivariate analysis, only the presence of lymphovascular invasion showed predictive factors for lymph node metastasis ( Table 5 ).
The details of patients with lymph node metastasis are described in Table 6 . One patient with mucosal cancer had a metastatic lymph node. He had the longest diameter of 5.3 cm and the presence of lymphovascular invasion. Two patients with lymph node metastasis were in the sm1 group and had lymphovascular invasion. In the present study, 13 of 140 patients displayed metastatic lymph nodes after gastrectomy. One patient with lymph node metastasis displayed advanced gastric cancer (depth of invasion, subserosa layer). Excepting 3 patients who were diagnosed with advanced gastric cancer after surgery, deepsubmucosal invasion (over sm2 or 500μm) and the presence of lymphovascular invasion showed significant differences for metastatic lymph nodes.
Especially in multivariate analysis, the presence of lymphovascular invasion was a predictive factor for metastatic lymph nodes. Therefore additional surgical treatment was positively necessary for patient with lymphovasular invasion or deepsubmucosal invasion.
In conclusion, because EMR/ESD of EGC is less traumatic than surgery, EMR/ESD should be considered as a first-line treatment in selected patients without risk of residual cancer or lymph node metastasis. But, additional surgical management should be done to eliminate the possibility of residual cancer or more advanced gastric cancer or metastatic lymph nodes for patients with deepsubmucosal invasion (over sm2 or 500μm) or presence of lymphovascular invasion.
